Commentary: Battle of the bioprosthetic valve blood thinners

J Thorac Cardiovasc Surg. 2023 Jan;165(1):69-70. doi: 10.1016/j.jtcvs.2021.02.064. Epub 2021 Feb 22.

Authors

Ahmed Alnajar¹, J Sunil Rao², Shari Messinger Cayetano², Joseph Lamelas³

Affiliations

¹ Division of Cardiothoracic Surgery, DeWitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, Miami, Fla. Electronic address: alnajarmd@gmail.com.
² Division of Biostatistics, Department of Public Health Sciences, University of Miami Miller School of Medicine, Miami, Fla.
³ Division of Cardiothoracic Surgery, DeWitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, Miami, Fla.

PMID: 33745710
DOI: 10.1016/j.jtcvs.2021.02.064

No abstract available

Publication types

Editorial
Comment

MeSH terms

Anticoagulants
Aortic Valve / surgery
Bioprosthesis*
Catheters
Heart Valve Prosthesis*
Humans
Prosthesis Failure

Substances

Anticoagulants